产品名称
MISSION® esiRNA, targeting human MAB21L2
description
Powered by Eupheria Biotech
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
AGCGGTTTGCACCTAAAGAAACACAAGGAGAACCCACTACAAACAAACAAACCCAGTCCAAACAACGCCTCCAGTAGGAAAAGAGGAAAACTGCGATAACACGACCCCCCGAGAAGAGACGAGACCAACACGCTGAGACTGTGGGGCGTCAGCAAACCTCCAAGTGCACGGCGGACTGAGTTGTACTTCGCAGCTCTCTGGACATTAATTACCTCCTGCACCTTCCATTTGGGGGAGGGTGAGGAAGAAGGCACTCACCTACACTGAGCGAAGAAGTCCTATCAGCGTGGAAGAGAAGTTTAAGAATGAACCACTGAATGTTTCGCTTTTATTTTTAAATTTACTTTGGCACTTAAAAAACCTCATTTCCAGATTTCTGGACAATCTCGGCTGCAGACATCTAAGCCTAACCTTTTGGTATCCTGAGTTTTTTCCCTCTCCTTCTCCTTCCTCACG
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Quality Level
Gene Information
human ... MAB21L2(10586), MAB21L2(10586)
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Dhifaf Sarhan et al.
JCI insight, 5(5) (2020-02-12)
Altered BM hematopoiesis and immune suppression are hallmarks of myelodysplastic syndrome (MDS). While the BM microenvironment influences malignant hematopoiesis, the mechanism leading to MDS-associated immune suppression is unknown. We tested whether mesenchymal stromal cells (MSCs) contribute to this process. Here
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持